DXCM 68.57 (-0.23%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Performance 3 years - DXCM ranking 30 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by performance 3 years
1. Natera NTRA
254.25
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
153.25
4. Medpace Holdings MEDP
81.92
5. Lantheus Holdings LNTH
69.72
6. Heska HSKA
41.31
7. PerkinElmer PKI
21.19
8. Quest Diagnostics DGX
17.24
9. Ortho Clinical Diagnostics Holdings OCDX
13.74
10. Waters WAT
4.93
11. Sera Prognostics SERA
0
12. Anixa Biosciences ANIX
-0.77
13. Laboratory Corp of America Holdings LH
-6.58
14. Twist Bioscience TWST
-13.65
15. Qiagen QGEN
-13.92
16. Syneos Health SYNH
-19.01
17. Olink Holding OLK
-22.2
18. Agilent Technologies A
-22.9
19. Mettler-Toledo MTD
-23.99
20. Thermo Fisher Scientific TMO
-26.79
21. IDEXX Laboratories IDXX
-27.35
22. Danaher DHR
-28.06
23. NeoGenomics NEO
-31.37
24. Exact Sciences EXAS
-32.89
25. Exagen XGN
-36.51
26. Guardant Health GH
-39.54
27. IQVIA Holdings IQV
-41.62
28. Bioventus BVS
-43.59
29. Icon ICLR
-44.22
30. DexCom DXCM
-46.96
31. CareDx CDNA
-48.22
32. Sotera Health SHC
-51.66
33. Personalis PSNL
-55.97
34. MaxCyte MXCT
-56.49
35. Myriad Genetics MYGN
-65.61
36. Psychemedics PMD
-65.96
37. Fulgent Genetics FLGT
-67
38. Charles River Laboratories CRL
-67.01
39. Global Cord Blood CO
-67.25
40. Enzo Biochem ENZ
-70.36
41. National Research NRC
-72.75
42. Biodesix BDSX
-72.97
43. Precipio PRPO
-76.99
44. Illumina ILMN
-78.57
45. MDxHealth MDXH
-79.79
46. Neogen NEOG
-82.13
47. Pacific Biosciences of California PACB
-83.52
48. bioAffinity Technologies BIAF
-88.45
49. Co-Diagnostics CODX
-88.94
50. Trinity Biotech TRIB
-89.06
51. Organovo Holdings ONVO
-89.19
52. Interpace Biosciences IDXG
-89.51
53. Neuronetics STIM
-91.07
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-93.93
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.88
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.